2006/140/EC: Commission Decision of 15 February 2006 concerning a specific financial contribution by the Community relating to the survey on TSE resistant PrP genes in goats presented by Cyprus for the year 2006 (notified under document number C(2006) 408)
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
1. The survey programme for TSE resistant PrP genes in goats presented by Cyprus is hereby approved for a period of 12 months starting from 1 January 2006. 2. The financial assistance from the Community for the programme referred to in paragraph 1 covers the costs (VAT excluded) incurred by Cyprus for laboratory testing up to 100 % in accordance with the provisions in Chapter 1 of the Annex. The total assistance shall be maximum EUR 47 500.
1. The financial assistance referred to under Article 1(2) shall be paid to Cyprus provided that the implementation of the programme shall be in conformity with the relevant provisions of Community law, including rules on competition and on the award of public contracts and subject to the conditions provided for in points (a) to (e): (a) bringing into force by 1 January 2006 the laws, regulations and administrative provisions for implementing the survey; (b) forwarding an intermediate financial and technical evaluation covering the first eight months of the survey, at the latest two months after the end of this period. The report shall conform to the model as set out in Chapter 2 of the Annex; (c) forwarding a final report by 31 March 2007 at the latest on the overall execution and results of the survey for the whole period during which Community financial assistance was granted. The report shall contain a technical and financial evaluation covering the year 2006, in accordance with the model as set out in Chapter 2 of the Annex, accompanied by justifying evidence as to the costs incurred; (d) these reports providing substantive and valuable technical and scientific information corresponding to the purpose of the Community intervention; (e) implementing the programme effectively. 2. When the time limit in subparagraph 1(c) is not respected, the contribution shall be reduced by 25 % on 1 May, 50 % on 1 June, 75 % on 1 July and 100 % on 1 September 2007.
The conversion rate for payments of reimbursement claims submitted in national currency in month ‘n’ shall be that of the 10th day of month ‘n+1’ or for the first preceding day for which a rate is quoted.
This Decision shall apply from 1 January 2006.
This decision is addressed to the Republic of Cyprus.
ANNEX CHAPTER 1 Financial assistance of the Community Costs Number of units Unitary cost in EUR Total cost in EUR Community assistence Sample collection 70 hours 21 1 470 None Histological examination 1 500 analyses 3,5 5 250 None PrP genotyping DNA sequencing 750 analyses 60 45 000 Costs of maximum 750 analyses at maximum EUR 60 per analysis Rapid testing Test kits and consumables 250 tests 14 3 500 Costs of maximum 250 tests at maximum EUR 10 per test Work 60 hours 20 1 200 None Coordination and evaluation of data 1 778 hours 14,5 25 780 None Traveling and accomodation costs CRL expert 1 trip 1 300 1 300 None Total Maximum EUR 47 500 CHAPTER 2 Technical and financial reporting Section A: Technical report Reporting period from to Determination of PrP genotype by DNA sequencing Number of samples with at codon 146 amino acid: Aspartic acid Serine … Other Histologically TSE + suspects, rapid test + Histologically TSE + suspects, rapid test – Histologically TSE – suspects, rapid test + Histologically TSE – suspects, rapid test – Healthy controls Section B: Statement on costs incurred for control ( 1 ) Reporting period from to Reference number of Commission Decision providing financial assistance: Costs incurred related to Number of units Costs incurred during the reporting period (national currency) PrP genotyping by DNA sequencing. Number of tests: Rapid testing. Number of tests: Rapid testing. Hours of work: ( 1 ) When presenting the final report referred to in Article 2(c), for each item a listing of all expenditures shall be provided together with a copy of supporting documents.
Source: EUR-Lex (Publications Office of the EU), © European Union, reuse permitted under Commission Decision 2011/833/EU.